These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18304034

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
    Chernov MF, Nakaya K, Kasuya H, Kato K, Ono Y, Yoshida S, Nakamura R, Suzuki T, Muragaki Y, Iseki H, Kubo O, Hori T, Takakura K.
    J Neurol Sci; 2009 Sep 15; 284(1-2):168-74. PubMed ID: 19497588
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.
    Mazzeo A, Toscano A, Stromillo ML, Battaglini M, Messina C, Federico A, Vita G, De Stefano N.
    J Neurol Sci; 2006 Jul 15; 246(1-2):31-5. PubMed ID: 16530227
    [Abstract] [Full Text] [Related]

  • 26. The use of glatiramer acetate in the treatment of multiple sclerosis.
    Wolinsky JS.
    Adv Neurol; 2006 Jul 15; 98():273-92. PubMed ID: 16400839
    [Abstract] [Full Text] [Related]

  • 27. Magnetic resonance spectroscopy features of normal-appearing white matter in patients with acute brucellosis.
    Kayabas U, Alkan A, Firat AK, Karakas HM, Bayindir Y, Yetkin F.
    Eur J Radiol; 2008 Mar 15; 65(3):417-20. PubMed ID: 17920223
    [Abstract] [Full Text] [Related]

  • 28. [Differences in the spectroscopy of the lesions of the remitting relapsing form of multiple sclerosis shown by magnetic resonance].
    Martínez-Bisbal MC, Celda B, Martí-Bonmat L, Casanova-Estruch B, Coret-Ferrer F.
    Rev Neurol; 2008 Mar 15; 34(9):807-12. PubMed ID: 12134339
    [Abstract] [Full Text] [Related]

  • 29. ALS surrogate markers. MRS.
    Kalra S, Arnold DL.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep 15; 5 Suppl 1():111-4. PubMed ID: 15512889
    [Abstract] [Full Text] [Related]

  • 30. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 31. Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?
    Rovaris M, Comi G, Filippi M.
    J Neurol Sci; 2005 Jun 15; 233(1-2):139-43. PubMed ID: 15949501
    [Abstract] [Full Text] [Related]

  • 32. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
    Watanabe H, Fukatsu H, Ito T, Iijima M, Mabuchi N, Sobue G.
    Nihon Rinsho; 2003 Aug 15; 61(8):1435-41. PubMed ID: 12962035
    [Abstract] [Full Text] [Related]

  • 33. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
    Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A.
    Mov Disord; 2008 Aug 15; 23(11):1560-6. PubMed ID: 18546325
    [Abstract] [Full Text] [Related]

  • 34. New options for early treatment of multiple sclerosis.
    Tintoré M.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [Abstract] [Full Text] [Related]

  • 35. Treatment monitoring and response prediction with proton MR spectroscopy in AD.
    Jessen F, Traeber F, Freymann K, Maier W, Schild HH, Block W.
    Neurology; 2006 Aug 08; 67(3):528-30. PubMed ID: 16894124
    [Abstract] [Full Text] [Related]

  • 36. Axonal dysfunction in the deep white matter in Machado-Joseph disease.
    D'Abreu A, França M, Appenzeller S, Lopes-Cendes I, Cendes F.
    J Neuroimaging; 2009 Jan 08; 19(1):9-12. PubMed ID: 18482370
    [Abstract] [Full Text] [Related]

  • 37. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec 08; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y.
    J Clin Neurosci; 2009 May 08; 16(5):635-41. PubMed ID: 19264490
    [Abstract] [Full Text] [Related]

  • 39. Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy.
    Marino S, De Luca M, Dotti MT, Stromillo ML, Formichi P, Galluzzi P, Mondelli M, Bramanti P, Federico A, De Stefano N.
    Neurology; 2007 Sep 18; 69(12):1261-9. PubMed ID: 17875914
    [Abstract] [Full Text] [Related]

  • 40. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
    Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.
    Psychiatry Clin Neurosci; 2009 Jun 18; 63(3):350-6. PubMed ID: 19566767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.